Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

JAK inhibitors show promise in treating difficult skin diseases.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Blocking certain brain processes reduces mating behavior in female rats.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Isotretinoin treatment increases p53 levels in the skin, which may explain its effectiveness against acne.

Isotretinoin treatment increases p53 levels in the skin, which may explain its effectiveness against acne.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Some drugs used to treat immune conditions may cause different types of hair loss.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ozonized olive oil reduces swelling but can cause inflammation and hair loss.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Alpha1-blockers effectively improve urinary symptoms in BPH, with alfuzosin and tamsulosin having fewer side effects.